Stock BGMD BG MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

BG Medicine, Inc. Share Price

Equities

BGMD

US08861T2069

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 09:06:41 06/12/2023 pm IST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for BG Medicine, Inc. -.--% -.--%
2016 BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015 CI
2016 BG Medicine Announces Board Changes CI

Financials

Sales 2014 2.79M 232M Sales 2015 1.57M 131M Capitalization 4.06M 339M
Net income 2014 -8M -667M Net income 2015 -5M -417M EV / Sales 2014 5.28 x
Net cash position 2014 1.16M 97.02M Net cash position 2015 1.52M 127M EV / Sales 2015 1.62 x
P/E ratio 2014
-1.87 x
P/E ratio 2015
-0.5 x
Employees 5
Yield 2014 *
-
Yield 2015
-
Free-Float 100%
More Fundamentals * Assessed data

Chart BG Medicine, Inc.

Dynamic Chart

Latest news about BG Medicine, Inc.

BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015 CI
BG Medicine Announces Board Changes CI
BG Medicine Withdraws 510(K) Premarket Notification for Proposed Additional Indication for the Bgm Galectin-3® Test CI
BG Medicine, Inc. Amends License and Distribution Agreement for Galectin-3 with Abbott Laboratories CI
BG Medicine, Inc. Announces Board Changes CI
Transcript : BG Medicine, Inc. - Special Call
BG Medicine, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015 CI
Certain Options of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015. CI
Certain Warrants of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015. CI
Certain shares of BG Medicine, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 11-NOV-2015. CI
Timothy Harris Resigns to Board of Directors and Audit Committee of BG Medicine, Inc CI
BG Medicine, Inc.(OTCPK:BGMD) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index CI
BG Medicine, Inc.(OTCPK:BGMD) dropped from S&P TMI Index CI
BG Medicine, Inc.(OTCPK:BGMD) dropped from CRSP US Total Market Index CI
BG Medicine, Inc.(NasdaqCM:BGMD) dropped from NASDAQ Composite Index CI
More news

Highs and lows

1 year
0.00
Extreme 0
0.02
3 years
0.00
Extreme 0
0.26
5 years
0.00
Extreme 0
0.26
10 years
0.00
Extreme 0
6.00
More quotes

Managers and Directors - BG Medicine, Inc.

Managers TitleAgeSince
Stephen Hall DFI
 Director of Finance/CFO 73 03/13/03
Members of the board TitleAgeSince
Harry Wilcox CHM
 Chairman 69 12/15/12
Jeffrey R. Luber BRD
 Director/Board Member 57 04/16/04
James O'Connor BRD
 Director/Board Member 67 17/15/17
More insiders

Company Profile

BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Sector
Pharmaceuticals
More about the company

Sector Diagnostic & Testing Substances Manufacturers

1st Jan change Capi.
BG MEDICINE, INC. Stock BG Medicine, Inc.
-.--% 11
DAAN GENE CO., LTD. Stock Daan Gene Co., Ltd.
-27.79% 1.48B
GENEREACH BIOTECHNOLOGY CORP. Stock GeneReach Biotechnology Corp.
-18.38% 57.39M
Diagnostic & Testing Substances Manufacturers
  1. Stock Market
  2. Equities
  3. BGMD Stock